• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about LEGN

Recent news which mentions LEGN

< Previous 1 2 3 4 5 Next >
LEGN Stock Earnings: Legend Biotech Beats EPS, Beats Revenue for Q2 2024
August 09, 2024
Tickers LEGN
Tags Market News LEGN NASDAQ:LEGN
From InvestorPlace
Will Genscript Cash Out Of Legend Biotech In The Face Of Fat Profit Temptation?
August 01, 2024
Tickers ASIA GNNSF LEGN
Tags contributors General Biotech
From Benzinga
Warner Bros. Discovery & Coinbase Are Among 10 Large Cap Stocks That Shined Most Last Week (July 14-July 20): Are The Others In Your Portfolio?
July 21, 2024
Tickers COIN DHI EPAM INFY
Tags DHI Market News EPAM
From Benzinga
Cintas Posts Upbeat Earnings, Joins CommScope Holding, Virtu Financial And Other Big Stocks Moving Higher On Thursday
July 18, 2024
Tickers BKU CHUY COMM CSIQ
Tags MTH VIRT Intraday Update
From Benzinga
The Latest Analyst Ratings For Legend Biotech
July 15, 2024
Tickers LEGN
Tags Benzinga BZI/AAR Market News
From Benzinga
Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients
July 02, 2024
Tickers JNJ LEGN NEWS
Tags Large Cap LEGN JNJ
From Benzinga
Assessing Legend Biotech: Insights From 15 Financial Analysts
June 21, 2024
Tickers LEGN
Tags LEGN Analyst Ratings Market News
From Benzinga
Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst
June 17, 2024
Tickers JNJ LEGN
Tags Movers Stories That Matter Truist Securities
From Benzinga
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
June 09, 2024
Tickers ACLS AGIO HALO IRTC
Tags NVDA Benzinga Top Stories
From Benzinga
Unveiling 18 Analyst Insights On Legend Biotech
June 04, 2024
Tickers LEGN
Tags LEGN Market News Analyst Ratings
From Benzinga
Legend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)
May 14, 2024
Tickers LEGN
Tags BZI/AAR Benzinga LEGN
From Benzinga
LEGN Stock Earnings: Legend Biotech Beats EPS, Misses Revenue for Q1 2024
May 13, 2024
Tickers LEGN
Tags Market News LEGN Earnings Reports
From InvestorPlace
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
April 19, 2024
Tickers BMY GILD JNJ LEGN
Tags Biotech News General
From Benzinga
Analyst Ratings For Legend Biotech
April 17, 2024
Tickers LEGN
Tags BZI/AAR Benzinga LEGN
From Benzinga
Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population
April 08, 2024
Tickers JNJ LEGN NEWS NVS
Tags Benzinga Expert Ideas Trading Ideas
From Benzinga
Unveiling 9 Analyst Insights On Legend Biotech
April 01, 2024
Tickers LEGN
Tags LEGN Analyst Ratings Market News
From Benzinga
GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy
March 20, 2024
Tickers ASIA BMY JNJ LEGN
Tags Benzinga contributors News
From Benzinga
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
March 18, 2024
Tickers BMY JNJ LEGN NEWS
Tags Health Care JNJ LEGN
From Benzinga
FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers
March 13, 2024
Tickers BMY JNJ LEGN NEWS
Tags Briefs Health Care JNJ
From Benzinga
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
March 13, 2024
Tickers BGNE CLOV HCM LEGN
Tags MXCT UNFI LEGN
From Benzinga
Earnings Scheduled For March 11, 2024
March 11, 2024
Tickers ALTO ASAN ASRT AVO
Tags HRTG LFMD ASRT
From Benzinga
Earnings Preview: Legend Biotech
March 08, 2024
Tickers LEGN
Tags Market News BZI/EP LEGN
From Benzinga
Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley
March 07, 2024
Tickers ACLX BMY GILD JNJ
Tags Benzinga Expert Ideas GILD
From Benzinga
What 4 Analyst Ratings Have To Say About Legend Biotech
March 07, 2024
Tickers LEGN
Tags LEGN Analyst Ratings Market News
From Benzinga
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
January 23, 2024
Tickers AZN BMY GILD GRCL
Tags Market News Stories That Matter NVS
From Benzinga
As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks?
January 10, 2024
Tickers ASIA BABA BGNE CHIR
Tags CHIR LEGN BABA
From Benzinga
Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
January 04, 2024
Tickers ACLX JNJ LEGN NEWS
Tags Biotech News ACLX
From Benzinga
Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback
December 29, 2023
Tickers ALNY ARWR IBB LEGN
Tags Equities SPY Stories That Matter
From Benzinga
Key Takeaways From Legend Biotech Analyst Ratings
December 19, 2023
Tickers LEGN
Tags BZI/AAR Benzinga Analyst Ratings
From Benzinga
Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say
December 11, 2023
Tickers ACLX JNJ LEGN
Tags Equities Movers Analyst Color
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap